Skip to main content
Metastatic diseaseLung Cancer

Metastatic lung cancer

My disease has spread. How are therapy options usually structured?

In metastatic disease, biomarkers and general condition are the primary determinants of therapy category, and clinical trials are often part of the discussion.

Not a diagnosis and not final medical advice. Must be reviewed by a doctor.

What changes at this stage

  • The general goal of therapy is to control the disease and maintain quality of life.
  • Biological markers determine whether targeted therapy is relevant.
  • The history of previous therapy determines the order of subsequent choices.

Options that are usually discussed

  • Systemic therapy based on markers

    If actionable markers are found, the target therapy category becomes the main discussion.

  • Immunotherapy, alone or in combination

    The relevance of immunotherapy is assessed by markers such as PD-L1 as well as the patient's condition.

  • Clinical trials

    Ongoing studies are often discussed when standard options are limited or have already been explored.

The decision remains with your doctor

This page explains the options that may be discussed; it does not choose one for you.

Practical next steps

  • Make sure all marker results are available in the form of a complete report.
  • Ask how many lines of therapy have been undertaken and what the response has been.
  • Assess suitability for the clinical trial that is recruiting participants.

Questions for your oncologist

  • What are the goals of therapy at this stage and how is its success assessed?
  • Which markers should I base my therapy choices on?
  • What options are available if this therapy no longer works?
  • Are there any clinical trials that might be appropriate?

Clinical trials

Registry studies for this group

International-patient access and site readiness have not been verified for any study.

Would you like to discuss this situation with someone?

Send a request with the context from this page so the documents and questions to prepare can be identified sooner.

After submission, a human navigator reviews your request and contacts you through your chosen channel. The WhatsApp message already includes this page context, so you do not need to explain from the beginning.

Clinical data is not requested in the form and is not sent to analytics. Do not send medical reports through WhatsApp or email; use the secure upload page. We do not promise eligibility or any treatment outcome.

Next steps

These suggestions come from links between entries in TanyaKanker's database, not from a medical judgement. Each suggestion includes why it appears.

Next to learn

To check

What you can do

  • Upload medical reports

    Build a case summary in twelve steps

    Reason: Often the most useful next step after reading this page

  • Request a second opinion

    Review of the treatment plan

    Reason: Relevant when a treatment plan is being considered

  • Consult a navigator

    A request is recorded with this page context

    Reason: For asking the next step directly

Recently updated

Want to follow changes on this topic? Save the page or follow the topic so it is easy to find again. View saved items.